Participation in colorectal cancer screening trials after first-time invitation: A systematic review

Endoscopy

Volumn 43, Issue 12, 2011, Pages 1059-1069

  Khalid De Bakker, C ^a   Jonkers, D ^a   Smits, K ^a   Mesters, I ^a   Masclee, A ^a   Stockbrgger, R ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; GROUPS BY AGE; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS (TOPIC); OCCULT BLOOD TEST; PATIENT PARTICIPATION; PRIORITY JOURNAL; RURAL AREA; SEX DIFFERENCE; SIGMOIDOSCOPY; SOCIAL STATUS; SYSTEMATIC REVIEW; URBAN AREA;

AGED; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; SIGMOIDOSCOPY;

EID: 82355181718     PISSN: 0013726X     EISSN: 14388812     Source Type: Journal    
DOI: 10.1055/s-0031-1291430     Document Type: Article

References (140)

1. Parkin DM, Bray F, Ferlay J et al. Global Cancer Statistics, 2002. CA Cancer J Clin: 2005; 55 74 108 (Pubitemid 40372904)
2. Bokemeyer B, Bock H, Huppe D et al. Screening colonoscopy for colorectal cancer prevention: Results from a German online registry on 269 000 cases. Eur J Gastroenterol Hepatol: 2009; 21 650 655
3. Hewitson P, Glasziou P, Irwig L et al. Screening for colorectal cancer using the faecal occult blood test, Hemoccult. Cochrane Database Syst Rev: 2007; CD001216
4. Towler B, Irwig L, Glasziou P et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, Hemoccult. BMJ: 1998; 317 559 565 (Pubitemid 28395924)
5. Atkin WS, Edwards R, Kralj-Hans I et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet: 2010; 375 1624 1633
6. Benson VS, Patnick J, Davies AK et al. Colorectal cancer screening: A comparison of 35 initiatives in 17 countries. Int J Cancer: 2008; 122 1357 1367 (Pubitemid 351287237)
7. Vijan S, Hwang EW, Hofer TP et al. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. Am J Med: 2001; 111 593 601 (Pubitemid 34088068)
8. Frazier AL, Colditz GA, Fuchs CS et al. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA: 2000; 284 1954 1961
9. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology: 1995; 109 1781 1790
10. Howard K, Salkeld G, Irwig L et al. High participation rates are not necessary for cost-effective colorectal cancer screening. J Med Screen: 2005; 12 96 102 (Pubitemid 40835141)
11. Vernon SW. Review: participation in colorectal cancer screening. J Natl Cancer Inst: 1997; 89 1406 1422 (Pubitemid 27419204)
12. Bowie JV, Curbow BA, Garza MA et al. A review of breast, cervical, and colorectal cancer screening interventions in older women. Cancer Control: 2005; 12 58 69
13. Beydoun H, Beydoun M. Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control: 2008; 19 339 359 [Epub 2007 Dec 18]
14. Subramanian S, Klosterman M, Amonkar MM et al. Adherence with colorectal cancer screening guidelines: a review. Prev Med: 2004; 38 536 550 (Pubitemid 38452879)
15. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst: 1997; 89 1406 1422 (Pubitemid 27419204)
16. Weed DL. Methodologic guidelines for review papers. J Natl Cancer Inst: 1997; 89 6 7
17. Higgins JPT, Green S. (editors). Cochrane handbook for systematic reviews of interventions [updated September 2008]. The Cochrane Collaboration: 2008; www.cochrane-handbook.org
18. Review Manager (RevMan) [computer program]. Version 5.0. The Cochrane Collaboration: 2008
19. Giorgi Rossi P, Federici A, Bartolozzi F et al. Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072]. BMC Public Health: 2005; 5 139 139
20. Deutekom M, Van Rijn AF, Dekker E et al. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur J Public Health: 2009; 19 400 402
21. Forbes GM, Fritschi L, Mendelson RM et al. Influences on participation in a community-based colorectal neoplasia screening program by virtual colonoscopy in Australia. Aust N Z J Public Health: 2004; 28 283 287 (Pubitemid 38868325)
22. Whynes DK, Frew EJ, Manghan CM et al. Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Public Health: 2003; 117 389 395 (Pubitemid 37321766)
23. Farrands PA, Hardcastle JD, Chamberlain J et al. Factors affecting compliance with screening for colorectal cancer. Community Med: 1984; 6 12 19 (Pubitemid 14165897)
24. Larsen IK, Grotmol T, Almendingen K et al. Lifestyle characteristics among participants in a Norwegian colorectal cancer screening trial. Eur J Cancer Prev: 2006; 15 10 19 (Pubitemid 43050921)
25. Blom J, Yin L, Liden A et al. Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancer. Int J Cancer: 2008; 122 1618 1623 (Pubitemid 351294972)
26. Vernon SW, Acquavella JF, Yarborough CM et al. Reasons for participation and nonparticipation in a colorectal cancer screening program for a cohort of high risk polypropylene workers. J Occup Med: 1990; 32 46 51 (Pubitemid 20032551)
27. Herbert C, Launoy G, Gignoux M. Factors affecting compliance with colorectal cancer screening in France: differences between intention to participate and actual participation. Eur J Cancer Prev: 1997; 6 44 52 (Pubitemid 27239517)
28. Bretthauer M, Gondal G, Larsen K et al. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol: 2002; 37 568 573 (Pubitemid 34525112)
29. Niv Y, Lev-El M, Fraser G et al. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut: 2002; 50 33 37 (Pubitemid 34028300)
30. Stroup D, Berlin J, Morton S et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA: 2000; 283 2008 2012 (Pubitemid 30214957)
31. Crotta S, Castiglione G, Grazzini G et al. Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community. Eur J Gastroenterol Hepatol: 2004; 16 33 37 (Pubitemid 39043700)
32. Grazzini G, Castiglione G, Ciabattoni C et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev: 2004; 13 19 26 (Pubitemid 38328115)
33. Berry DP, Clarke P, Hardcastle JD et al. Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Br J Surg: 1997; 84 1274 1276 (Pubitemid 27400281)
34. UK Colorectal Cancer Screening Pilot Group Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ: 2004; 329 133
35. Steele RJ, McClements PL, Libby G et al. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut: 2009; 58 530 535
36. Dybdahl JH, Haug K, Bakkevold K et al. Screening for occult faecal blood loss in a community by means of Hemoccult II slides and a tetramethylbenzidine test. Scand J Gastroenterol: 1984; 19 343 349 (Pubitemid 14105201)
37. Lindholm E, Berglund B, Haglind E et al. Factors associated with participation in screening for colorectal cancer with faecal occult blood testing. Scand J Gastroenterol: 1995; 30 171 176
38. Carlsson U, Ekelund G, Eriksson R et al. Evaluation of possibilities for mass screening for colorectal cancer with Hemoccult fecal blood test. Dis Colon Rectum: 1986; 29 553 557 (Pubitemid 16012736)
39. Brevinge H, Lindholm E, Buntzen S et al. Screening for colorectal neoplasia with faecal occult blood testing compared with flexible sigmoidoscopy directly in a 5556 years old population. Int J Colorect Dis: 1997; 12 291 295 (Pubitemid 27478332)
40. Malila N, Oivanen T, Malminiemi O et al. Test, episode, and programme sensitivities of screening for colorectal cancer as a public health policy in Finland: experimental design. [see comment]. BMJ: 2008; 337 2261
41. Hakkinen I, Paasivuo R, Partanen P. Screening of colorectal tumours using an improved faecal occult blood test. Quantitative aspects. Gut: 1988; 29 1194 1197
42. Malila N, Hakama M, Pukkala E. A 25-year follow-up of a population screened with faecal occult blood test in Finland. Acta Oncol: 2007; 46 1103 1106 (Pubitemid 350058887)
43. Kronborg O, Fenger C, Sondergaard O et al. Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol: 1987; 22 677 686 (Pubitemid 17124880)
44. Rasmussen M, Kronborg O, Fenger C et al. Possible advantages and drawbacks of adding flexible sigmoidoscopy to hemoccult-II in screening for colorectal cancer. A randomized study. Scand J Gastroenterol: 1999; 34 73 78 (Pubitemid 29074790)
45. Adamsen S, Kronborg O. Acceptability and compliance in screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol: 1984; 19 531 534 (Pubitemid 14083547)
46. van Rossum LG, van Rijn AF, Laheij RJ et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology: 2008; 135 82 90 (Pubitemid 351899018)
47. Hol L, Wilschut JA, van Ballegooijen M et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer: 2009; 100 1103 1110
48. Peris M, Espinas JA, Munoz L et al. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). J Med Screen: 2007; 14 81 86 (Pubitemid 47067762)
49. Tarraga P, Garcia-Olmo D, Celada A et al. Colorectal cancer screening through detection of fecal occult blood in a controlled health zone. Rev Esp Enferm Dig: 1999; 91 335 344
50. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet: 1996; 348 1472 1477 (Pubitemid 26400242)
51. Box V, Nichols S, Lallemand RC et al. Haemoccult compliance rates and reasons for non-compliance. Public Health: 1984; 98 16 25 (Pubitemid 14166949)
52. Hart AR, Gay SP, Donnelly A et al. Screening for colorectal cancer in Market Harborough, UK: A community-based programme. Eur J Gastroenterol Hepatol: 1994; 6 519 522 (Pubitemid 24150181)
53. Marjoram J, Strachan R, Allan A et al. Screening for colorectal cancer: a general-practice-based study. Br J Gen Pract: 1996; 46 283 286 (Pubitemid 26154829)
54. Verne J, Kettner J, Mant D et al. Self-administered faecal occult blood tests do not increase compliance with screening for colorectal cancer: results of a randomized controlled trial. Eur J Cancer Prev: 1993; 2 301 305
55. Hardcastle JD, Balfour TW, Amar SS. Screening for symptomless colorectal cancer by testing for occult blood in general practice. Lancet: 1980; 1 791 793 (Pubitemid 10134727)
56. Farrands PA, Hardcastle JD. Colorectal screening by a self-completion questionnaire. Gut: 1984; 25 445 447 (Pubitemid 14144014)
57. Mant D, Fuller A, Northover J et al. Patient compliance with colorectal cancer screening in general practice. Br J Gen Pract: 1992; 42 18 20
58. Hart AR, Barone TL, Gay SP et al. The effect on compliance of a health education leaflet in colorectal cancer screening in general practice in central England. J Epidemiol Community Health: 1997; 51 187 191 (Pubitemid 27229236)
59. Verne JE, Aubrey R, Love SB et al. Population based randomized study of uptake and yield of screening by flexible sigmoidoscopy compared with screening by faecal occult blood testing. BMJ: 1998; 317 182 185 (Pubitemid 28325545)
60. Jansen JH. Participation in the first and second round of a mass-screening for colorectal cancer. Soc Sci Med: 1984; 18 633 636
61. Goulard H, Boussac-Zarebska M, Ancelle-Park R et al. French colorectal cancer screening pilot programme: results of the first round. J Med Screen: 2008; 15 143 148
62. Launoy G, Smith TC, Duffy SW et al. Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer: 1997; 73 220 224 (Pubitemid 27448822)
63. Manfredi S, Piette C, Durand G et al. Colonoscopy results of a French regional FOBT-based colorectal cancer screening program with high compliance. Endoscopy: 2008; 40 422 427 (Pubitemid 351696381)
64. Denis B, Ruetsch M, Strentz P et al. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut: 2007; 56 1579 1584 (Pubitemid 350033197)
65. Tazi MA, Faivre J, Dassonville F et al. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen: 1997; 4 147 151 (Pubitemid 28270255)
66. Herbert C, Launoy G, Thezee Y et al. Participants' characteristics in a French colorectal cancer mass screening campaign. Prev Med: 1995; 24 498 502
67. Tifratene K, Eisinger F, Rinaldi Y et al. Colorectal cancer screening program: cost effectiveness of systematic recall letters. Gastroenterol Clin Biol: 2007; 31 929 933
68. Federici A, Giorgi Rossi P, Borgia P et al. The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: a cluster randomized controlled trial. J Med Screen: 2005; 12 83 88 (Pubitemid 40835139)
69. Federici A, Marinacci C, Mangia M et al. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy. Cancer Detect Prev: 2006; 30 347 353 (Pubitemid 44429940)
70. Fric P, Zavoral M, Dvorakova H et al. An adapted program of colorectal cancer screening-7 years experience and cost-benefit analysis. Hepatogastroenterology: 1994; 41 413 416 (Pubitemid 24340634)
71. Preisich P, Siba S, Szakatsy E. Mass screening for colorectal cancer in Hungary. J R Soc Med: 1987; 80 352 353 (Pubitemid 17120617)
72. Lee FI. Screening for colorectal cancer in a factory-based population with Fecatest. Br J Cancer: 1983; 48 843 847 (Pubitemid 14210827)
73. Hart AR, Glover N, Howick-Baker J et al. An industry based approach to colorectal cancer screening in an asymptomatic population. Postgrad Med J: 2003; 79 646 649 (Pubitemid 38019215)
74. Hart AR, Eaden J, Barnett S et al. Colorectal cancer prevention. An approach to increasing compliance in a faecal occult blood test screening programme. J Epidemiol Community Health: 1998; 52 818 820 (Pubitemid 28523880)
75. Parente F, Marino B, DeVecchi N et al. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer. Br J Surg: 2009; 96 533 540
76. Grazzini G, Ciatto S, Cislaghi C et al. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence. J Med Screen: 2008; 15 175 181
77. Federici A, Barca A, Baiocchi D et al. Can colorectal cancer mass-screening organization be evidence-based? Lessons from failures: the experimental and pilot phases of the Lazio program. BMC Public Health: 2008; 8 318
78. Courtier R, Casamitjana M, Macia F et al. Participation in a colorectal cancer screening programme: influence of the method of contacting the target population. Eur J Cancer Prev: 2002; 11 209 213 (Pubitemid 34753879)
79. Grazzini G, Castiglione G, Isu A et al. Colorectal cancer screening by fecal occult blood testing: results of a population-based experience. Tumori: 2000; 86 384 388
80. Segnan N, Senore C, Andreoni B et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst: 2005; 97 347 357 (Pubitemid 40425953)
81. Segnan N, Senore C, Andreoni B et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology: 2007; 132 2304 2312 (Pubitemid 46900821)
82. Castiglione G, Zappa M, Grazzini G et al. Screening for colorectal cancer by faecal occult blood test: comparison of immunochemical tests. J Med Screen: 2000; 7 35 37 (Pubitemid 30305465)
83. Castiglione G, Zappa M, Grazzini G et al. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. Br J Cancer: 1996; 74 141 144 (Pubitemid 26231992)
84. Armitage N, Hardcastle JD, Amar SS et al. A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer. Br J Cancer: 1985; 51 799 804 (Pubitemid 15056993)
85. Hoff G, Bretthauer M. Appointments timed in proximity to annual milestones and compliance with screening: randomised controlled trial. BMJ: 2008; 337 2794
86. Hoff G, Vatn M, Gjone E et al. Epidemiology of polyps in the rectum and sigmoid colon. Design of a population screening study. Scand J Gastroenterol: 1985; 20 351 355 (Pubitemid 15089054)
87. Blom J, Liden A, Jeppsson B et al. Compliance and findings in a Swedish population screened for colorectal cancer with sigmoidoscopy. Eur J Surg Oncol: 2002; 28 827 831 (Pubitemid 35402292)
88. Santavirta J. Screening, sigmoidoscopy in persons aged 60 years. Colorectal Dis: 2002; 4 184 188 (Pubitemid 34567876)
89. Bleiberg H, Autier P, Huet F et al. Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population. Ann Oncol: 2006; 17 1328 1332 (Pubitemid 44288226)
90. Brotherstone H, Vance M, Edwards R et al. Uptake of population-based flexible sigmoidoscopy screening for colorectal cancer: a nurse-led feasibility study. J Med Screen: 2007; 14 76 80 (Pubitemid 47067761)
91. Gray M, Pennington CR. Screening sigmoidoscopy: a randomised trial of invitation style. Health Bull: 2000; 58 137 140
92. Senore C, Segnan N, Rossini FP et al. Screening for colorectal cancer by once only sigmoidoscopy: a feasibility study in Turin, Italy. J Med Screen: 1996; 3 72 78 (Pubitemid 126736079)
93. Brotherstone H, Miles A, Robb KA et al. The impact of illustrations on public understanding of the aim of cancer screening. Patient Educ Couns: 2006; 63 328 335 (Pubitemid 44511872)
94. Pye G, Christie M, Chamberlain JO et al. A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload. J Epidemiol Community Health: 1988; 42 66 71
95. Thomas WM, Pye G, Hardcastle JD et al. Faecal occult blood screening for colorectal neoplasia: a randomized trial of three days or six days of tests. Br J Surg: 1990; 77 277 279 (Pubitemid 20103760)
96. Robinson MH, Pye G, Thomas WM et al. Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance. Eur J Surg Oncol: 1994; 20 545 548 (Pubitemid 24340603)
97. Robinson MH, Marks CG, Farrands PA et al. Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up. Br J Surg: 1996; 83 500 501 (Pubitemid 26120772)
98. Marbet UA, Bauerfeind P, Brunner J et al. Colonoscopy is the preferred colorectal cancer screening method in a population-based program. Endoscopy: 2008; 40 650 655
99. Corbett M, Chambers SL, Shadbolt B et al. Colonoscopy screening for colorectal cancer: the outcomes of two recruitment methods. Med J Aust: 2004; 181 423 427 (Pubitemid 39419747)
100. Cole SR, Young GP, Esterman A et al. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen: 2003; 10 117 122 (Pubitemid 38296846)
101. Hughes K, Leggett B, Del Mar C et al. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community. Aust N Z J Public Health: 2005; 29 358 364 (Pubitemid 41670838)
102. King J, Fairbrother G, Thompson C et al. Colorectal cancer screening: optimal compliance with postal faecal occult blood test. Aust N Z J Surg: 1992; 62 714 719
103. Dent OF, Bartrop R, Goulston KJ et al. Participation in faecal occult blood screening for colorectal cancer. Soc Sci Med: 1983; 17 17 23 (Pubitemid 13142951)
104. Multicentre Australian Colorectal-neoplasia Screening (MACS) group A comparison of colorectal neoplasia screening tests: A multicentre community-based study of the impact of consumer choice. Med J Aust: 2006; 184 546 550
105. Cole SR, Smith A, Wilson C et al. An advance notification letter increases participation in colorectal cancer screening. J Med Screen: 2007; 14 73 75 (Pubitemid 47067760)
106. Cole SR, Young GP, Byrne D et al. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner. J Med Screen: 2002; 9 147 152 (Pubitemid 36135339)
107. Scott RG, Edwards JT, Fritschi L et al. Community-based screening by colonoscopy or computed tomographic colonography in asymptomatic average-risk subjects. Am J Gastroenterol: 2004; 99 1145 1151 (Pubitemid 38917822)
108. Edwards JT, Mendelson RM, Fritschi L et al. Colorectal neoplasia screening with CT colonography in average-risk asymptomatic subjects: community-based study. Radiology: 2004; 230 459 464 (Pubitemid 38133807)
109. Collett JA, Olynyk JK, Platell CF. Flexible sigmoidoscopy screening for colorectal cancer in average-risk people: update of a community-based project. Med J Aust: 2000; 173 463 466
110. Segarajasingam DS, Ang EBH, Fritschi L et al. Seasonal variation of participation in colorectal neoplasia screening by colonoscopy or CT colonography. Aust N Z J Public Health: 2006; 30 287 288 (Pubitemid 44559814)
111. Krevsky B, Niewiarowski T, League R et al. Flexible sigmoidoscopy screening in an industrial setting. Am J Gastroenterol: 1992; 87 1759 1762
112. Elwood TW, Erickson A, Lieberman S. Comparative educational approaches to screening for colorectal cancer. Am J Public Health: 1978; 68 135 138 (Pubitemid 8297536)
113. Myers R, Trock B, Lerman C et al. Adherence to colorectal cancer screening in an HMO population. Prev Med: 1990; 19 502 514 (Pubitemid 20270280)
114. Myers RE, Ross EA, Wolf TA et al. Behavioral interventions to increase adherence in colorectal cancer screening. Medical Care: 1991; 29 1039 1050
115. Nichols S, Koch E, Lallemand RC et al. Randomised trial of compliance with screening for colorectal cancer. Br Med J (Clin Res Ed): 1986; 293 107 110 (Pubitemid 16096049)
116. Schroy PC, Wilson S, Afdhal N. Feasibility of high-volume screening sigmoidoscopy using a flexible fiberoptic endoscope and a disposable sheath system. Am J Gastroenterol: 1996; 91 1331 1337 (Pubitemid 26236364)
117. Neale AV, Demers RY, Herman S. Compliance with colorectal cancer screening in a high-risk occupational group. J Occup Med: 1989; 31 1007 1012 (Pubitemid 20023736)
118. Vernon SW, Acquavella JF, Douglass TS et al. Factors associated with participation in an occupational program for colorectal cancer screening. J Occup Med: 1989; 31 458 463 (Pubitemid 19137454)
119. Walsh JM, Salazar R, Terdiman JP et al. Promoting use of colorectal cancer screening tests. Can we change physician behavior? J Gen Intern Med: 2005; 20 1097 1101 (Pubitemid 43110258)
120. Percac-Lima S, Grant RW, Green AR et al. A culturally tailored navigator program for colorectal cancer screening in a community health center: A randomized, controlled trial. J Gen Intern Med: 2009; 24 211 217
121. Vinker S, Nakar S, Rosenberg E et al. The role of family physicians in increasing annual fecal occult blood test screening coverage: a prospective intervention study. Isr Med Assoc J: 2002; 4 424 425 (Pubitemid 34624717)
122. Wei N, Nakama H, Li T. Screen compliance rates in 14-years annual screening program for colorectal cancer with immunochemical fecal occult blood test - identification of higher priority subjects in health education. Eur J Med Res: 1998; 3 341 344
123. Slater PE, Fich A, Zimmerman J et al. Recruitment of subjects for fecal occult blood screening: a comparison of two methods in Jerusalem. J Clin Gastroenterol: 1985; 7 51 54 (Pubitemid 15126543)
124. Ore L, Hagoel L, Lavi I et al. Screening with faecal occult blood test (FOBT) for colorectal cancer: assessment of two methods that attempt to improve compliance. Eur J Cancer Prev: 2001; 10 251 256 (Pubitemid 32530369)
125. Elliot MS, Levenstein JH, Wright JP. Faecal occult blood testing in the detection of colorectal cancer. Br J Surg: 1984; 71 785 786 (Pubitemid 14041887)
126. Bat L, Pines A, Ron E et al. A community-based program of colorectal screening in an asymptomatic population: evaluation of screening tests and compliance. Am J Gastroenterol: 1986; 81 647 651 (Pubitemid 16034264)
127. Niv Y, Lev-El M, Fraser G et al. Protective effect of faecal occult blood test screening for colorectal cancer: worse prognosis for screening refusers. Gut: 2002; 50 33 37 (Pubitemid 34028300)
128. Hou SI, Chen PH. Home-administered fecal occult blood test for colorectal cancer screening among worksites in Taiwan. Prev Med: 2004; 38 78 84
129. Niv Y, Gold B, Fraser GM. Screening for colonic neoplastic lesions using flexible sigmoidoscopy in employees of a nuclear research center and members of collective settlements. Isr J Med Sci: 1996; 32 1167 1172 (Pubitemid 27042432)
130. Levi Z, Chorev N, Segal N et al. Screening for colorectal cancer in personnel of an academic medical center. Dig Dis Sci: 2007; 52 2301 2304 (Pubitemid 47246513)
131. Power E, Miles A, von Wagner C et al. Uptake of colorectal cancer screening: system, provider and individual factors and strategies to improve participation. Future Oncol: 2009; 5 1371 1388
132. Centers for Disease Control and Prevention (CDC) Use of colorectal cancer tests-United States, 2002, 2004, and 2006. MMWR Morb Mortal Wkly Rep: 2008; 57 253 258
133. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med: 2000; 133 573 584
134. Bastos J, Peleteiro B, Gouveia J et al. The state of the art of cancer control in 30 European countries in 2008. Int J Cancer: 2010; 126 2700 2715
135. Saito H. Colorectal cancer screening using immunochemical faecal occult blood testing in Japan. J Med Screen: 2006; 13 6 7
136. Brenner H, Hoffmeister M, Brenner G et al. Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies. Eur J Cancer: 2009; 45 2027 2033
137. Haidinger G, Waldhoer T, Vutuc C. Self-reported colonoscopy screening in Austria. Eur J Cancer Prev: 2008; 17 354 357
138. Keighley MR, OMorain C, Giacosa A et al. Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev: 2004; 13 257 262 (Pubitemid 39096077)
139. Robinson MH, Marks CG, Farrands PA et al. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests. Br J Surg: 1994; 3 448 451 (Pubitemid 24124835)
140. Bleiberg H, Autier P, Huet F et al. Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population. Annals of Oncology. 2006; 1328 1332